A study to evaluate the impact of different controlled ovarian stimulation protocols on physical and psychological burden in patients undergoing In-Vitro Fertilization/In-Vitro Cytoplasmic Sperm Injection

Organon India Pvt Limited0 个研究点目标入组 669 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Each subject must be female who will be undergoing Controlled Ovarian Stimulation (COS) as a part of first cycle IVF ICSI using recombinant Follicle Stimulating Hormone (rFSH using pen delivery system) with GnRH antagonist (eg ganirelix or cetrorelix) protocol, or a female using Human Menopausal Gonadotropin (hMG) with conventional long GnRH agonist, or mixed protocol with hMG and Urinary Follicle Stimulating Hormone (uFSH)or rFSH with conventional long GnRH agonist (eg leuprolide, etc)
•Each subject must be 18 to 45 years of age
•Use of drugs (gonadotropin, GnRH agonist or antagonist, Human Chorionic Gonadotropin [hCG], hMG, uFSH, rFSH) must be consistent with approved label
•Each subject must be willing and able to provide written informed consent for the study
•Each subject must be able to fill the study specific questionnaires

•Subject with prior history of ovarian hyper-stimulation syndrome (OHSS)
•Subject using depot formulation of GnRH agonist
•Subject already receiving GnRH agonist or antagonist, stimulation protocol
•Subject currently enrolled in another observational study or clinical trial
•Subject suffering from any neurological or psychiatric illness
•Subject has any clinically significant condition or situation, other than the condition being studied, that in the opinion of the Investigator, would interfere with the study evaluations or optimal participation in the study

发起方

Organon India Pvt Limited